Paul R. Fonteyne - Director at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
APLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Paul R. Fonteyne since 12/22/2023

Holdings reported by Paul R. Fonteyne for Apellis Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16.4K $1.05M $63.69 Jan 1, 2024 Direct
Stock Option (Right to Buy) 5.75K $381K $66.30 Jan 1, 2024 Direct Common Stock

Transactions reported by Paul R. Fonteyne for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.